Drugs / M72/AS01E
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01262976 | Jan 2011 → Jul 2012 | tuberculosis | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | M72/AS01E | “receive 2 doses of M72/AS01E (M72/AS01E groups) or saline” PMID 30407329 ↗ Nov 2018 |